Titre :
  • Phase II study of carboplatin in recurrent ovarian cancer: severe hematologic toxicity in previously treated patients.
Auteur : Colombo, Nicoletta ; Speyer, J L ; Green, M ; Canetta, R ; Beller, U ; Wernz, J C ; Meyers, Michel ; Widman, T ; Blum, R H ; Piccart-Gebhart, Martine
Informations sur la publication : Cancer chemotherapy and pharmacology, 23, 5, (page 323-328)
Statut de publication : Publié, 1989
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Acute Disease
Antineoplastic Agents -- administration & dosage
Antineoplastic Agents -- adverse effects
Blood -- drug effects
Carboplatin
Carcinoma -- blood
Carcinoma -- complications
Carcinoma -- drug therapy
Creatinine -- blood
Drug Evaluation
Female
Humans
Kidney Failure, Chronic -- blood
Neoplasm Recurrence, Local -- blood
Neoplasm Recurrence, Local -- complications
Neoplasm Recurrence, Local -- drug therapy
Organoplatinum Compounds -- administration & dosage
Organoplatinum Compounds -- adverse effects
Ovarian Neoplasms -- blood
Ovarian Neoplasms -- complications
Ovarian Neoplasms -- drug therapy
Platelet Count -- drug effects
Prospective Studies
Thrombocytopenia -- blood
Thrombocytopenia -- chemically induced
Time Factors
Note : Journal Article
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0344-5704 
info:pmid/2650904